How Government Policy Promotes High Drug Prices

Posted on October 29, 2015 by henrykotula • Posted in Uncategorized • Tagged Antitrust, Competition, Health Policy, Monopoly, Pharmaceutical, Pharmaceutical Costs, Pharmaceutical Pricing • Leave a comment

http://healthaffairs.org/blog/2015/10/29/how-government-policy-promotes-high-drug-prices/

The coming storm – five market trends driving healthcare costs higher

Posted on October 24, 2015 by henrykotula • Posted in Uncategorized • Tagged Antitrust, Health Insurance Underwriting, Health Policy, Health System, Hospital, Pharmaceutical Costs, Reform • Leave a comment

http://stateofreform.com/commentary/opinion/2015/08/the-coming-storm-five-market-trends-driving-healthcare-costs-higher/

PBM vs. PBA: The pros and cons

Posted on September 30, 2015 by henrykotula • Posted in Uncategorized • Tagged Pharmaceutical Costs, Pharmacy Benefit Administrator, Pharmacy Benefit Management, Value Based Health Care • Leave a comment

http://managedhealthcareexecutive.modernmedicine.com/managed-healthcare-executive/news/pbm-vs-pba-pros-and-cons

Friday Feedback: The Continuing Drug Cost Debate

Posted on September 26, 2015 by henrykotula • Posted in Uncategorized • Tagged Free Market Economy, Health Policy, Pharmaceutical Costs • Leave a comment

http://www.medpagetoday.com/PrimaryCare/GeneralPrimaryCare/53740?xid=nl_mpt_DHE_2015-09-26&eun=g885344d0r

Balancing the free market economy with patient care

Avalere identifies 4 trends affecting payers in 2015

Posted on February 19, 2015 by henrykotula • Posted in Uncategorized • Tagged Healthcare, Payer Trends, Pharmaceutical Costs, Reform • Leave a comment

http://www.fiercehealthpayer.com/story/avalere-identifies-4-trends-affecting-payers-2015/2015-02-13?utm_medium=nl&utm_source=internal

Drug Cost Dilemma Evades Solution

Posted on February 12, 2015 by henrykotula • Posted in Uncategorized • Tagged Healthcare, Pharmaceutical, Pharmaceutical Costs, Reform • Leave a comment

http://www.healthleadersmedia.com/content/HEP-308226/Drug-Cost-Dilemma-Evades-Solution